MedTrace Logo

A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

NCT04953000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2023-07-11

No results posted yet for this study

Summary

The main aim of this study is to learn about changes in the lowest blood levels of Factor VIII in men and boys when upgraded from standard prophylaxis with Advate to individualized prophylaxis with Advate.

No study medicines will be provided to participants in this study. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study. Participants will need to visit the study doctor 3 times in total during the study. During these visits, study data will be collected by the study doctor.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-19
Primary Completion
2023-04-04
Completion
2023-04-04

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953000 on ClinicalTrials.gov